| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 869 | 0 | 0 | 27.195 | 1.932 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 869 | 0 | 0 | 27.195 | 127.935 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 689 | 7.464 | 2.445 | 17.854 | 142.093 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 179 | -7.464 | -2.445 | 9.342 | -14.158 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 153 | -7.464 | -2.445 | 9.070 | -14.177 |
| Employees | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 3 |
Check the financial reports for the company - Dna Residence S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 534 | 529 | 520 | 510 | 500 | 491 | 99.223 | 99.531 | 115.396 | 114.063 |
| Current Assets | 4.578 | 4.531 | 4.455 | 4.373 | 4.288 | 4.621 | 7.101 | 8.330 | 36.132 | 234.271 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 14 | 14 | 14 | 165.185 |
| Receivables | 4.538 | 4.492 | 4.416 | 4.335 | 4.251 | 3.917 | 4.028 | 5.261 | 29.771 | 31.547 |
| Cash | 40 | 39 | 39 | 38 | 37 | 704 | 3.059 | 3.054 | 6.347 | 37.539 |
| Shareholders Funds | -1.930 | -1.911 | -1.878 | -1.844 | -1.808 | -1.621 | -9.049 | -11.522 | -2.417 | -16.581 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.043 | 6.971 | 6.853 | 6.727 | 6.597 | 6.733 | 115.373 | 119.382 | 153.945 | 364.915 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4120 - 4120" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Dna Residence S.r.l.